STOCK TITAN

Eton Pharmaceuticals: EcoR1 reports 8.6% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Eton Pharmaceuticals, Inc. (ETON) Schedule 13G/A reports that EcoR1 Capital, LLC and Oleg Nodelman each beneficially own 2,470,920 common shares, or 8.6%. EcoR1 Capital Fund Qualified, L.P. reports beneficial ownership of 2,286,883 shares, or 7.9%. Each reported position carries shared voting and dispositive power, with no sole voting or dispositive power. The percentages are based on 28,842,215 shares outstanding as of November 2, 2026.

EcoR1 is the Qualified Fund’s general partner and investment adviser, and Nodelman is EcoR1’s control person. The reporting persons state they filed jointly, not as a group, and disclaim beneficial ownership except to the extent of their respective pecuniary interests.

Reported beneficial ownership — EcoR1 Capital, LLC and Oleg Nodelman 2,470,920 shares Each reports this amount, representing 8.6% of the class.
Reported ownership percentage — EcoR1 Capital, LLC and Oleg Nodelman 8.6% Each reports this percentage based on 28,842,215 shares outstanding as of November 2, 2026.
Reported beneficial ownership — EcoR1 Capital Fund Qualified, L.P. 2,286,883 shares Reported as 7.9% of the class.
Reported ownership percentage — EcoR1 Capital Fund Qualified, L.P. 7.9% Based on 28,842,215 shares outstanding as of November 2, 2026.
Common shares outstanding 28,842,215 shares As of November 2, 2026; used to calculate the reported ownership percentages.
beneficial ownership regulatory
"Each reporting person also disclaims beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared Voting Power 2,470,920.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 2,470,920.00"
pecuniary interest regulatory
"except to the extent of that person's pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ETON shares do EcoR1 Capital and the Qualified Fund report owning?

EcoR1 Capital, LLC and Oleg Nodelman each report beneficial ownership of 2,470,920 shares, or 8.6%; EcoR1 Capital Fund Qualified, L.P. reports 2,286,883 shares, or 7.9%. The percentages use 28,842,215 shares outstanding as of November 2, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





29772L108

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 28,842,215 Shares of Common Stock outstanding on November 2, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 28,842,215 Shares of Common Stock outstanding on November 2, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 28,842,215 Shares of Common Stock outstanding on November 2, 2026, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2026.


SCHEDULE 13G



EcoR1 Capital, LLC
Signature:/s/ Oleg Nodelman
Name/Title:Manager
Date:11/16/2026
Oleg Nodelman
Signature:/s/ Oleg Nodelman
Name/Title:Reporting person
Date:11/16/2026
EcoR1 Capital Fund Qualified, L.P.
Signature:/s/ Oleg Nodelman
Name/Title:Manager of the General Partner, EcoR1 Capital, LLC
Date:11/16/2026

Keep reading